Ashley Hall - 03 Mar 2026 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Mar 2026, 18:20:07 UTC
Prior SEC filing
22 Sep 2025
Next SEC filing
23 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jun Yoon, Attorney-in-Fact

Key filing fact

Ashley Hall filed Form 4 for Structure Therapeutics Inc. (GPCR) on 05 Mar 2026.

Key facts

  • This page summarizes Ashley Hall's Form 4 filing for Structure Therapeutics Inc. (GPCR).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 05 Mar 2026, 18:20.

Change

  • Previous filing in this sequence was filed on 22 Sep 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001801842 Primary reporting owner

Hall Ashley

Relationship
Chief Development Officer
Address
C/O STRUCTURE THERAPEUTICS INC., 601 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO
Signature
/s/ Jun Yoon, Attorney-in-Fact
Signature date
05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GPCR transaction

Ordinary Shares

Tax liability

Transaction value
Shares
-4,836
Change %
-4.3%
Price
$20.99*
Shares after
107,481
Date
03 Mar 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GPCR transaction Derivative

American Depositary Shares

Award

Transaction value
Shares
+225
Change %
Price
$0.000000*
Shares after
225
Date
20 May 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
675
Exercise price
Footnotes
F1, F3, F4
GPCR transaction Derivative

American Depositary Shares

Award

Transaction value
Shares
+237
Change %
+105%
Price
$0.000000*
Shares after
462
Date
20 Nov 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
711
Exercise price
Footnotes
F1, F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Footnote F2

Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Footnote F3

Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

Footnote F4

Voluntary reporting of the acquisition of 225 ADSs by the Reporting Person on May 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.

Footnote F5

Voluntary reporting of the acquisition of 237 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .